Pediatric bronchial Dieulafoy's disease: a biopsy-sparing bronchoscopic approach with selective bronchial artery embolization
-
By
-
Weiqing Liu
-
Jiasi Zhou
-
Jia Guo
-
Tuanjie Wang
-
Yuping Xu
-
Shujun Li
-
May 8, 2026
-
Clinical Scorecard: Bronchial Dieulafoy's Disease in Pediatrics: A Bronchoscopic Technique Minimizing Biopsy with Targeted Bronchial Artery Embolization
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Children under 18 years with hemoptysis. |
| Care Setting | |
Key Highlights
- Standardized pathway emphasizes biopsy-sparing bronchoscopy.
- All patients achieved immediate hemostasis after selective bronchial artery embolization.
- No major complications or recurrence observed during follow-up.
- Highlight the rarity of BDD in pediatric cases.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- F
- o
- l
- l
- o
- w
- -
- u
- p
-
- f
- o
- r
-
- r
- e
- c
- u
- r
- r
- e
- n
- c
- e
-
- o
- v
- e
- r
-
- 3
- -
- 3
- 6
-
- m
- o
- n
- t
- h
- s
-
- p
- o
- s
- t
- -
- B
- A
- E
-
- f
- o
- r
-
- c
- o
- n
- f
- i
- r
- m
- e
- d
-
- B
- D
- D
-
- c
- a
- s
- e
- s
- .
Risks
Patient & Prescribing Data
Emphasize early progression to bronchial artery embolization when BDD is suspected; include specific treatment protocols if available.
Clinical Best Practices
- Prioritize airway safety and avoid biopsy at suspicious lesions.
- Utilize computed tomography angiography for non-invasive evaluation.
- Coordinate multidisciplinary care involving pulmonology and interventional radiology.
- Consider CTA in cases where bronchoscopy is not feasible.
Related Resources & Content
